Logo image of SEER

SEER INC (SEER) Stock Fundamental Analysis

USA - NASDAQ:SEER - US81578P1066 - Common Stock

2.1707 USD
-0.03 (-1.33%)
Last: 10/21/2025, 10:40:50 AM
Fundamental Rating

4

Overall SEER gets a fundamental rating of 4 out of 10. We evaluated SEER against 57 industry peers in the Life Sciences Tools & Services industry. No worries on liquidiy or solvency for SEER as it has an excellent financial health rating, but there are worries on the profitability. SEER is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SEER has reported negative net income.
SEER had a negative operating cash flow in the past year.
In the past 5 years SEER always reported negative net income.
SEER had a negative operating cash flow in each of the past 5 years.
SEER Yearly Net Income VS EBIT VS OCF VS FCFSEER Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

The Return On Assets of SEER (-25.46%) is worse than 71.93% of its industry peers.
The Return On Equity of SEER (-28.48%) is worse than 61.40% of its industry peers.
Industry RankSector Rank
ROA -25.46%
ROE -28.48%
ROIC N/A
ROA(3y)-20.82%
ROA(5y)-16.61%
ROE(3y)-22.99%
ROE(5y)-18.14%
ROIC(3y)N/A
ROIC(5y)N/A
SEER Yearly ROA, ROE, ROICSEER Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

With a Gross Margin value of 49.94%, SEER perfoms like the industry average, outperforming 56.14% of the companies in the same industry.
SEER's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for SEER so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.13%
GM growth 5YN/A
SEER Yearly Profit, Operating, Gross MarginsSEER Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K

More info and screens

8

2. Health

2.1 Basic Checks

SEER does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SEER has been reduced compared to 1 year ago.
SEER has less shares outstanding than it did 5 years ago.
SEER has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SEER Yearly Shares OutstandingSEER Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
SEER Yearly Total Debt VS Total AssetsSEER Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 0.24, we must say that SEER is in the distress zone and has some risk of bankruptcy.
SEER has a Altman-Z score of 0.24. This is in the lower half of the industry: SEER underperforms 75.44% of its industry peers.
There is no outstanding debt for SEER. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.24
ROIC/WACCN/A
WACC10.47%
SEER Yearly LT Debt VS Equity VS FCFSEER Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 19.15 indicates that SEER has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 19.15, SEER belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 18.51 indicates that SEER has no problem at all paying its short term obligations.
SEER's Quick ratio of 18.51 is amongst the best of the industry. SEER outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 19.15
Quick Ratio 18.51
SEER Yearly Current Assets VS Current LiabilitesSEER Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for SEER have decreased by -8.59% in the last year.
SEER shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.53%.
The Revenue has been growing by 159.68% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-8.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.71%
Revenue 1Y (TTM)10.53%
Revenue growth 3Y28.88%
Revenue growth 5Y159.68%
Sales Q2Q%31.87%

3.2 Future

Based on estimates for the next years, SEER will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.36% on average per year.
The Revenue is expected to grow by 36.94% on average over the next years. This is a very strong growth
EPS Next Y3.75%
EPS Next 2Y13.21%
EPS Next 3Y10.22%
EPS Next 5Y11.36%
Revenue Next Year23.95%
Revenue Next 2Y23.97%
Revenue Next 3Y29.83%
Revenue Next 5Y36.94%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SEER Yearly Revenue VS EstimatesSEER Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M
SEER Yearly EPS VS EstimatesSEER Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SEER. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SEER. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEER Price Earnings VS Forward Price EarningsSEER Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SEER Per share dataSEER EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.21%
EPS Next 3Y10.22%

More info and screens

0

5. Dividend

5.1 Amount

SEER does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEER INC

NASDAQ:SEER (10/21/2025, 10:40:50 AM)

2.1707

-0.03 (-1.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners62.64%
Inst Owner Change0%
Ins Owners3.27%
Ins Owner Change0.29%
Market Cap122.30M
Analysts82.86
Price Target3.06 (40.97%)
Short Float %3.19%
Short Ratio11.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.46%
Min EPS beat(2)12.56%
Max EPS beat(2)16.35%
EPS beat(4)2
Avg EPS beat(4)4.2%
Min EPS beat(4)-10.69%
Max EPS beat(4)16.35%
EPS beat(8)5
Avg EPS beat(8)7.73%
EPS beat(12)9
Avg EPS beat(12)7.83%
EPS beat(16)12
Avg EPS beat(16)6.7%
Revenue beat(2)2
Avg Revenue beat(2)16.38%
Min Revenue beat(2)5.91%
Max Revenue beat(2)26.85%
Revenue beat(4)3
Avg Revenue beat(4)14.38%
Min Revenue beat(4)-0.72%
Max Revenue beat(4)26.85%
Revenue beat(8)4
Avg Revenue beat(8)4.13%
Revenue beat(12)7
Avg Revenue beat(12)3.29%
Revenue beat(16)11
Avg Revenue beat(16)12.07%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)3.13%
EPS NQ rev (3m)-16.98%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.76%
Revenue NY rev (1m)-1.41%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.51
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB 0.42
EV/EBITDA N/A
EPS(TTM)-1.39
EYN/A
EPS(NY)-1.02
Fwd EYN/A
FCF(TTM)-0.96
FCFYN/A
OCF(TTM)-0.91
OCFYN/A
SpS0.29
BVpS5.12
TBVpS5.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.46%
ROE -28.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.94%
FCFM N/A
ROA(3y)-20.82%
ROA(5y)-16.61%
ROE(3y)-22.99%
ROE(5y)-18.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.13%
GM growth 5YN/A
F-Score6
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 45.52%
Cap/Sales 17.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 19.15
Quick Ratio 18.51
Altman-Z 0.24
F-Score6
WACC10.47%
ROIC/WACCN/A
Cap/Depr(3y)149.91%
Cap/Depr(5y)200.28%
Cap/Sales(3y)45.15%
Cap/Sales(5y)185.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.71%
EPS Next Y3.75%
EPS Next 2Y13.21%
EPS Next 3Y10.22%
EPS Next 5Y11.36%
Revenue 1Y (TTM)10.53%
Revenue growth 3Y28.88%
Revenue growth 5Y159.68%
Sales Q2Q%31.87%
Revenue Next Year23.95%
Revenue Next 2Y23.97%
Revenue Next 3Y29.83%
Revenue Next 5Y36.94%
EBIT growth 1Y11.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year22.56%
EBIT Next 3Y13.1%
EBIT Next 5Y11.88%
FCF growth 1Y23.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y17.56%
OCF growth 3YN/A
OCF growth 5YN/A